Cargando…
FEN1 endonuclease as a therapeutic target for human cancers with defects in homologous recombination
Synthetic lethality strategies for cancer therapy exploit cancer-specific genetic defects to identify targets that are uniquely essential to the survival of tumor cells. Here we show RAD27/FEN1, which encodes flap endonuclease 1 (FEN1), a structure-specific nuclease with roles in DNA replication and...
Autores principales: | Guo, Elaine, Ishii, Yuki, Mueller, James, Srivatsan, Anjana, Gahman, Timothy, Putnam, Christopher D., Wang, Jean Y. J., Kolodner, Richard D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431096/ https://www.ncbi.nlm.nih.gov/pubmed/32719125 http://dx.doi.org/10.1073/pnas.2009237117 |
Ejemplares similares
-
The Swr1 chromatin-remodeling complex prevents genome instability induced by replication fork progression defects
por: Srivatsan, Anjana, et al.
Publicado: (2018) -
The unstructured linker of Mlh1 contains a motif required for endonuclease function which is mutated in cancers
por: Torres, Kendall A., et al.
Publicado: (2022) -
Activation of Saccharomyces cerevisiae Mlh1-Pms1 Endonuclease in a Reconstituted Mismatch Repair System
por: Smith, Catherine E., et al.
Publicado: (2015) -
Seamless Gene Tagging by Endonuclease-Driven Homologous Recombination
por: Khmelinskii, Anton, et al.
Publicado: (2011) -
The prognostic significance of Flap Endonuclease 1 (FEN1) in breast ductal carcinoma in situ
por: Al-Kawaz, Abdulbaqi, et al.
Publicado: (2021)